New hope for tough leukemia: precision drug combo trial launches
Disease control
Not yet recruiting
This phase 2 trial tests whether personalized drug combinations can help people with relapsed or treatment-resistant T-cell acute lymphoblastic leukemia (T-ALL). Researchers will assign patients to one of several targeted therapies based on lab tests. The main goal is to see if t…
Phase: PHASE2 • Sponsor: Philippe ROUSSELOT • Aim: Disease control
Last updated Jun 27, 2026 12:09 UTC